Institutional members access full text with Ovid®

HIV-1 Tat affects the programming and functionality of human CD8+ T cells by modulating the expression of T-box transcription factors

Sforza, Fabioa,*; Nicoli, Francescoa,*; Gallerani, Eleonoraa; Finessi, Valentinaa; Reali, Evab; Cafaro, Aurelioc; Caputo, Antonellad; Ensoli, Barbarac; Gavioli, Riccardoa

doi: 10.1097/QAD.0000000000000315
Basic Science

Objective: HIV infection is characterized by several immune dysfunctions of both CD8+ and CD4+ T cells as hyperactivation, impairment of functionality and expansion of memory T cells. CD8+ T-cell dysfunctions have been associated with increased expression of T-bet, Eomesdermin and pro-inflammatory cytokines, and with down-regulation of CD127. The HIV-1 trans-activator of transcription (Tat) protein, which is released by infected cells and detected in tissues of HIV-positive individuals, is known to contribute to the dysregulation of CD4+ T cells; however, its effects on CD8+ T cells have not been investigated. Thus, in this study, we sought to address whether Tat may affect CD8+ T-cell functionality and programming.

Methods: CD8+ T cells were activated by T-cell receptor engagement in the presence or absence of Tat. Cytokine production, killing capacity, surface phenotype and expression of transcription factors important for T-cell programming were evaluated.

Results: Tat favors the secretion of interleukin-2, interferon-γ and granzyme B in CD8+ T cells. Behind this functional modulation we observed that Tat increases the expression of T-bet, Eomesdermin, Blimp-1, Bcl-6 and Bcl-2 in activated but not in unstimulated CD8+ T lymphocytes. This effect is associated with the down-regulation of CD127 and the up-regulation of CD27.

Conclusion: Tat deeply alters the programming and functionality of CD8+ T lymphocytes.

aDepartment of Life Sciences and Biotechnology, University of Ferrara, Ferrara

bLaboratory of Translational Immunology, I.R.C.C.S. Istituto Ortopedico Galeazzi, Milan

cNational AIDS Center, Istituto Superiore di Sanità, Rome

dDepartment of Molecular Medicine, University of Padova, Padova, Italy.

*Dr Fabio Sforza and Dr Francesco Nicoli contributed equally to the writing of this article.

Correspondence to Professor Riccardo Gavioli, PhD, Department of Life Sciences and Biotechnology, University of Ferrara, via Fossato di Mortara 74, 44121 Ferrara, Italy. E-mail: r.gavioli@unife.it

Received 29 January, 2014

Revised 20 April, 2014

Accepted 22 April, 2014

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.AIDSonline.com).

© 2014 Lippincott Williams & Wilkins, Inc.